Sciabola d’argento, Montano eroico

TOKYO – Aldo Montano chiude la sua lunghissima e strepitosa carriera di schermidore con una grande prestazione in pedana, sfiorando l’impresa insieme ai suoi compagni della sciabola. Lo schermidore livornese, alla soglia dei 43 anni, ha conquistato infatti l’argento nella sciabola a squadre insieme ai compagni Luca Curatoli, Enrico Berrè e Luigi Samele, sfiorando l’alloro più prestigioso… Read More in Corriere Canadese >>>

Aldo Montano closes his amazing fencing career with a silver in Tokyo

TORONTO – July 28, 2021: “Is it an endless career? It’s a finished career.” Like this Aldo Montano he replies, smiling, to journalists after winning the silver medal in the men’s team saber in Tokyo 2020 which ends his long career. I think it is right to arrive here, I have waited a year longer than I had planned, I have suffered a lot because I have a lot of problems and pains. That’s okay. It was a really difficult and complicated year and I had to manage a serious problem and it is a joy to have arrived here, competitive and to have given my contribution. Take home this medal that I feel I have helped the boys to conquer it all. It was wonderful to end a career like this “, added the blue champion who closes with a medal on the day Federica Pellegrini competed for the last time in the Games in her 200 freestyle. Continue reading

Mix of vaccines, problem for traveling abroad

TORONTO – One dose of one vaccine, one of another: when in the absence of available alternatives at the time of recall, injections of different vaccines were offered, many people accepted. After all, the scientific community tried to reassure everyone, the benefits would have been the same. Then, slowly, the effectiveness of a mixed vaccination regimen was questioned. Or at least doubts have arisen for lack of an experimental basis on which to base the decision. And many countries in the world have decided not to authorize, for example, vaccines such as AstraZeneca, called into question for the risk of developing thrombotic events such as heart attacks and pulmonary embolisms. Continue reading